2023-04-01 14706868 2024-03-31 14706868 2023-04-01 2024-03-31 14706868 uk-core:WithinOneYear 2024-03-31 14706868 uk-core:AfterOneYear 2024-03-31 14706868 uk-core:ShareCapital 2024-03-31 14706868 uk-core:RetainedEarningsAccumulatedLosses 2024-03-31 14706868 uk-bus:Director1 2023-04-01 2024-03-31 iso4217:GBP xbrli:pure 14706868 uk-bus:AuditExemptWithAccountantsReport 2023-04-01 2024-03-31 14706868 uk-bus:FRS102 2023-04-01 2024-03-31 14706868 uk-bus:FilletedAccounts 2023-04-01 2024-03-31 14706868 uk-bus:PrivateLimitedCompanyLtd 2023-04-01 2024-03-31
Draft
Arca Biologistics Limited
Registered Number:14706868
For the year ended 31 March 2024
England and Wales
Unaudited Financial Statements
2
Draft
For the year ended 31 March 2024
Arca Biologistics Limited
Contents Page
1
Statement of Financial Position
2 to 3
Notes to the Financial Statements
3
Draft
Registered Number :
14706868
As at 31 March 2024
Arca Biologistics Limited
Statement of Financial Position
£
2024
Notes
Fixed assets
Property, plant and equipment
46,433
2
46,433
Current assets
Trade and other receivables
12,859
3
Cash and cash equivalents
4,770
17,629
Trade and other payables: amounts falling due within one
year
(12,190)
4
5,439
Net current assets
Total assets less current liabilities
51,872
Trade and other payables: amounts falling due after more
than one year
(10,000)
5
41,872
Net assets/liabilities
Capital and reserves
Called up share capital
120,100
Retained earnings
(78,228)
41,872
Shareholders' funds
For the year ended 31 March 2024 the company was entitled to exemption from audit under Section 477 of the Companies Act 2006 relating to small companies.
The members have not required the company to obtain an audit of its financial statements for the year ended 31 March 2024 in accordance with Section 476 of the Companies Act 2006
The directors acknowledge their responsibilities for:a) ensuring that the company keeps proper accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
b) preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of
each financial year and of its profit or loss for each financial year in accordance with the requirements of Section
394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial
statements, so far as applicable to the company.
In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.
The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.
Mr Bruce Kennedy Director
These financial statements were approved and authorised for issue by the Board on 30 May 2024 and were signed by:
The notes form part of these financial statements
1 of 3
4
Draft
For the year ended 31 March 2024
Arca Biologistics Limited
Notes to the Financial Statements
Statutory Information
Arca Biologistics Limited is a private limited company, limited by shares, domiciled in England and Wales, registration
number 14706868.
Registered address:
Cheshire House 164 Main Road
Goostrey
Crewe
England
CW4 8JP
The presentation currency is £ sterling.
1. Accounting policies
Basis of preparing the financial statements
These financial statements have been prepared in accordance with the provisions of Section 1A of Financial
Reporting Standard 102 ''The Financial Reporting Standard applicable in the UK and Republic of Ireland'' and the
Companies Act 2006. The financial statements have been prepared under the historical costs convention as
modified by the revaluation of certain assets.
2. Property, plant and equipment
Plant and
Machinery
£
Cost or
valuation
54,627
Additions
At 31 March 2024
54,627
Provision for depreciation and impairment
Charge for year
8,194
At 31 March 2024
8,194
At 31 March 2024
Net book value
46,433
3. Trade and other receivables
2024
£
Trade debtors
10,239
Other debtors
2,620
12,859
2 of 3
5
Draft
For the year ended 31 March 2024
Arca Biologistics Limited
Notes to the Financial Statements Continued
4. Trade and other payables: amounts falling due within one year
2024
£
Trade creditors
10,940
Other creditors
1,250
12,190
5. Trade and other payables: amounts falling due after more than one year
2024
£
Amounts owed to group undertaking and undertaking in which the
company has a participating interest
10,000
6. Average number of persons employed
During the year the average number of employees was 4
3 of 3